Nikon Aims For $1.2 Billion Medical Optics Business In Four Years
This article was originally published in PharmAsia News
Executive Summary
Nikon has set aside more than $280 million from its camera profits to invest in medical start-ups that could help it develop new products more quickly and build a $1.2 billion business by the end of fiscal year 2016.
You may also be interested in...
Scotland's MGB Plots Phase III For Promising Antibacterial
With a late-stage compound on its hands, MGB is currently in discussions with several biotech and pharma companies and also with venture capitalists to continue late-stage development of a novel antibiotic which could transform treatment of Clostridium difficile.
AstraZeneca Vaccine May Only Gain EU Approval In Under 70s
AZ and the EU are at loggerheads over supplies of the COVID-19 vaccine. On top of that, its marketing authorization will present dilemmas.
Moment Of Truth In EU For Amarin’s ‘Multi-Billion-Dollar Opportunity’ Drug
The European Medicines Agency is expected to decide soon whether Amarin’s fish oil pill, Vascepa, should win pan-EU marketing approval for reducing cardiovascular risk.
Need a specific report? 1000+ reports available
Buy Reports